Diabetes

DIABETES

Empagliflozin May Allow Patients With Type 1 Diabetes to Forgo Carbohydrate Counting

Incorporation of empagliflozin in a closed-loop, automated insulin pump for patients with type 1 diabetes may allow for the elimination of carbohydrate counting.

Latest News

Bone Turnover Lower Among Men With Type 2 Diabetes Mellitus, A1c Greater Than 7%

Endocrinology Advisor Contributing Writer

Study authors identified whether the hemoglobin A1c threshold level where reduction in bone turnover begins.

Psychological Considerations for Patients With Painful Diabetic Neuropathy

Jessica Nye, PhD

This article discusses how to assess patients with neuropathic pain in relation to psychological aspects of their health and cognitive behavioral interventions to improve their quality of life.

Greater HbA1c Variability May Raise Risk for CVD in T2DM

Large visit-to-visit hemoglobin A1c (HbA1c) variability is associated with an increased risk for cardiovascular disease in patients with type 2 diabetes.

Can Vitamin D Lower Diabetes Risk and Reduce Cancer Progression, Mortality?

Endocrinology Advisor Contributing Writer

Vitamin D supplementation is associated with a 13% decrease in progression to diabetes in patients with prediabetes.

Hyperglycemia in Childhood T1D Associated With Small but Notable Functional Deficits

Endocrinology Advisor Contributing Writer

Researchers sought to identify whether there were any functional deficits in the developing brains of children with type 1 diabetes due to episodes of hyperglycemia.

Ertugliflozin Plus Insulin Improves Body Weight, HbA1c, and More for T2DM

Endocrinology Advisor Contributing Writer

Researchers sought to determine whether ertugliflozin plus insulin would help redice body weight, systolic blood pressure, HbA1c, and other metrics among individuals with T2DM.

An overweight child's stomach with a tape measure

Best Practices in Youths and Adolescents with Obesity and Type 2 Diabetes Mellitus

Endocrinology Advisor Contributing Writer

At the Endocrine Society’s annual meeting, ENDO 2021, Seema Kumar from the Mayo Clinic presented a review covering the evaluation and assessment of pediatric obesity and type 2 diabetes mellitus.

Cardiovascular Disease and All-Cause Mortality Not Linked to Heart Rate Variability

Jessica Nye, PhD

The investigators studied associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants’ baseline glycemic state.

Once-Weekly Semaglutide Promising for Weight Loss

Individuals with overweight or obesity receiving once-weekly subcutaneous semaglutide plus lifestyle intervention achieved sustained, clinically relevant reductions in body weight.

When medication is needed to obtain blood glucose targets, insulin and metformin are preferred.1 Metformin is preferable to insulin if it provides sufficient glucose control because it is associated with a lower risk for hypoglycemia and weight gain; however, its use might increase the risk for prematurity. When insulin is needed, referral to a specialty center offering team-based care should be considered because of the complexity of insulin dosing in pregnant patients.1 Glyburide may be considered, but more recent studies have associated its use with a higher risk for neonatal hypoglycemia and macrosomia compared with insulin or metformin.1 Other agents have not been adequately studied. Regardless of agent(s) used, patients should be informed that most oral agents cross the placenta, and all lack long-term safety data.1

Study Looks at T2DM, Metformin Use, and Breast Cancer Risk

The risks for breast cancer in women with type 2 diabetes (T2D) may be influenced by long-term metformin use.

Next post in Type 1 Diabetes

Diabetes

Empagliflozin May Allow Patients With Type 1 Diabetes to Forgo Carbohydrate Counting

Latest News

Bone Turnover Lower Among Men With Type 2 Diabetes Mellitus, A1c Greater Than 7%

Psychological Considerations for Patients With Painful Diabetic Neuropathy

Greater HbA1c Variability May Raise Risk for CVD in T2DM

Can Vitamin D Lower Diabetes Risk and Reduce Cancer Progression, Mortality?

Hyperglycemia in Childhood T1D Associated With Small but Notable Functional Deficits

Ertugliflozin Plus Insulin Improves Body Weight, HbA1c, and More for T2DM

Best Practices in Youths and Adolescents with Obesity and Type 2 Diabetes Mellitus

Cardiovascular Disease and All-Cause Mortality Not Linked to Heart Rate Variability

Once-Weekly Semaglutide Promising for Weight Loss

Study Looks at T2DM, Metformin Use, and Breast Cancer Risk

Want to read more?

Persistent Adverse Pregnancy Outcomes Still Exist for Women With Type 1 or Type 2 Diabetes